Market growth is majorly driven by the high incidence of diabetic foot ulcers and other target wounds, the availability of reimbursement in developed economies, and the rising number of burn cases. However, the high cost of enzymatic products is expected to hamper market growth to a certain extent during the forecast period.
[131 Pages Report] The wound debridement market is estimated to grow from USD 822 million in 2020 to USD 1,162 million by 2025, at a CAGR of 7.2%.
Download PDF Brochure:
Ultrasonic debridement products segment to witness the highest growth during the forecast period
Based on product, the wound debridement market is categorized into enzymatic, autolytic, mechanical, surgical, ultrasonic, and others. The ultrasonic debridement products segment is expected to grow at the highest growth rate during the forecast period. This is primarily attributed to factors such as their high efficacy in debriding and precision (lack of damage to healthy tissue) during debridement.
Hospitals accounted for the largest share of the wound debridement market, by end user, in 2019
Based on end-user, the wound debridement market has been segmented into hospitals, clinics, and other end users. In 2019, the hospitals segment accounted for the largest market share. The availability of infrastructure and the presence of skilled professionals in hospitals are the major driving factors for this segment.
Wound Debridement Market
North America is the largest regional market for wound debridement
The wound debridement market, by region, has been segmented into North America, Europe, the Asia Pacific, and the Rest of the World (RoW). North America is the largest market for wound debridement, followed by Europe. Growth in the North American market can be attributed to the increasing prevalence of diabetes, high penetration of enzymatic debridement products, and strong market player presence. However, the Asia Pacific is expected to register the highest CAGR during the forecast period. Growth in this region is driven by the presence of a large patient population and increasing awareness regarding advanced healthcare products.
Key Market Players
Prominent players in the wound debridement market include Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Coloplast (Denmark), ConvaTec (UK), Mölnlycke Healthcare (Sweden), Lohmann & Rauscher (Germany), Integra Lifesciences (US), Arobella Medical, LLC (US), Advancis Medical (UK), RLS Global (Sweden), DeRoyal Industries (US), Sanara MedTech Inc. (US), and EZ Debride (US).